Immunogenicity after six months of BNT162b2 vaccination in frail or disabled nursing home residents: the COVID-A Study.

Sergio Salmerón RíosElisa Belén Cortés ZamoraAlmudena Avendaño CéspedesLuis Romero RizosPedro Manuel Sánchez-JuradoGinés Sánchez-NievasMarta Mas RomeroMaría Teresa Tabernero SahuquilloJosé Joaquín Blas SeñaladaAntonio Murillo RomeroInmaculada García NoguerasJuan de Dios Estrella CazallaFernando Andrés-PretelVolker Martin LauschkeJustin StebbingPedro Abizanda Soler

Published in: Journal of the American Geriatrics Society (2021)

Older adults in LTCFs experience a rapid loss of antibodies between over the first six months after the second dose of BNT162b2 vaccine. Only pre-vaccination COVID-19 is associated with a slower rate of antibodies decrease. Our data support immunization with a third dose in this vulnerable, high-risk population. This article is protected by copyright. All rights reserved.

Keyphrases

coronavirus disease
sars cov
respiratory syndrome coronavirus
big data
machine learning
deep learning
artificial intelligence